Your session is about to expire
← Back to Search
Peer Health Coaching for HIV (ACCESS Trial)
ACCESS Trial Summary
This trial is testing whether connecting with a trained peer health coach via videoconferencing can help improve ART adherence and HIV-viral load in Black and Hispanic HIV-infected adolescents and young adults, compared to those who only have access to a web-based HIV ART adherence education.
ACCESS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowACCESS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ACCESS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 29 years old.I am HIV positive.I am currently on medication for HIV.
- Group 1: HIV-infected youth: Intervention
- Group 2: HIV-infected youth: control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are enrolled in this experiment?
"Affirmative. The information on clinicaltrials.gov verifies that this research project is actively recruiting participants, which began being posted on February 14th 2022 and was last updated in March 24th 2022. 120 individuals are required to be enlisted from 2 different locales."
Is this medical investigation open to those elderly sixty and over?
"This trial is exclusively available to those aged 18-29. There are also 108 clinical trials for minors and 352 medical studies targeting the elderly cohort."
Does this research still need participants?
"According to the current information on clinicaltrials.gov, this medical trial is recruiting participants with its first posting made on February 14th 2022 and most recent update taking place on March 24th 2022."
Could you elucidate the key aims of this research endeavor?
"This 3-day clinical trial aims to assess Adherence self-efficacy. Secondary objectives include Client Satisfaction and Ease of Use of the web platform, Change in Knowledge about ART, and Change in Social support and Isolation. To measure these goals, a modified Client Satisfaction Questionnaire, Perceived Ease of Use Scale, HIV Treatment Knowledge Scale (scores range from 0-21), and ATN iTech short measure with scores ranging between 25 - 125 will be used."
Am I a qualified participant for this research endeavor?
"120 participants aged between 18 and 29 with HIV are welcome to submit an application for this trial. Notably, the following conditions must be met: No cognitive problems that could interfere with videoconferencing or study completion; Ages 18-29 years old."
Share this study with friends
Copy Link
Messenger